Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Price & Market Data

Price: $0.708

Daily Change: -$0.0617 / 8.71%

Daily Range: $0.70 - $0.79

Market Cap: $10,118,771

Daily Volume: 552,808

Performance Metrics

1 Week: -62.62%

1 Month: -90.75%

3 Months: -90.75%

6 Months: -90.75%

1 Year: -90.75%

YTD: -90.75%

About Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Key metrics for Lakewood-Amedex Biotherapeutics, Inc. (LABT). Current price: 0.708, daily change: -$0.0617 / 8.71%. Market cap: 10,118,771. Performance across all periods for quick analysis.

Company Details

Employees: 5

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Selected stocks

Big Tree Cloud Holdings Limited (DSY)

X Financial (XYF)

TechPrecision Corporation (TPCS)

Akso Health Group (AHG)

Data Storage Corporation (DTST)